UP!

WST $395.71

WST target price
395.71
0
449
West Pharmaceutical Services, Inc.
Type
Public
Traded as NYSE: WST
S&P 400 Component
Industry Medical devices
Pharmaceuticals
Founded 1923
Headquarters Exton, Pennsylvania, United States
Key people
Eric Green (CEO)
Revenue Increase US $1.192 billion (2011)
Operating income
Increase US $109.6 million (2011)
Net income
Increase US $75.5 million (2011)
Number of employees
6,300 (2011)
Website www.westpharma.com

West Pharmaceutical Services, Inc. is a designer and manufacturer of pharmaceutical packaging and delivery systems. Founded in 1923 by Herman O. West and J.R. Wike of Philadelphia, the company is headquartered in Exton, Pennsylvania. In its early years of development, West produced rubber components for packaging injectable drugs, providing a sterile environment for the producers of penicillin and insulin.

West manufactures components and systems for injectable drug delivery and plastic packaging, and delivery system components for the healthcare and consumer products markets.

West has been ranked a 'Top Workplace' in the Greater-Philadelphia area by Philly.com in 2010, 2011, and 2012.

On January 29, 2003, an accumulation of combustible polyethelene powder caused an explosion at a West rubber-manufacturing plant in Kinston, North Carolina.

In 2005, West acquired The Tech Group, Scottsdale, Ariz. and Medimop Medical Projects Ltd., Ra’anana, Israel.

China, Qingpu

Japan, Tokyo

Singapore, Jurong

India, Hyderabad

India, SriCity

Denmark, Horsens

Denmark, Roskilde

England, Bodmin

England, St. Austell

France, Le Nouvion

France, Normandy

Germany, Eschweiler

Germany, Stolberg

Ireland, Dublin

Israel, Ra'anana

Serbia, Kovin

Arizona, Phoenix

Arizona, Scottsdale

Arizona, Tempe

Florida, Clearwater

Florida, St. Petersburg

Indiana, Frankfort

México, Cuernavaca

Michigan, Walker

Nebraska, Kearney

New Jersey, Washington

North Carolina, Kinston

Pennsylvania, Jersey Shore

Pennsylvania, Lititz

Pennsylvania, Upper Darby

Pennsylvania, Williamsport

Puerto Rico, Cayey

Texas, Athens

Brazil, São Paulo


Q reports

Period Date Adjusted Actuals EPS GAAP EPS
Q1 2023 2023-04-27 Future report Set alerts
Q4 2022 2023-02-16 1.77 1.77
Q3 2022 2022-10-27 2.03 2.03
Q2 2022 2022-07-28 2.47 2.47
Q1 2022 2022-04-28 2.30 2.30
Q4 2021 2022-02-17 2.04 2.04
Q3 2021 2021-10-28 2.06 2.06
Q2 2021 2021-07-29 2.46 2.46
Q1 2021 2021-04-29 2.05 2.05
Q4 2020 2021-02-18 1.34 1.34

Ratings

2016-06-09 Reiterated Rating Jefferies Group Hold $67.00
2016-05-13 Reiterated Rating Janney Montgomery Scott Buy $69.00 to $90.00
2016-03-22 Initiated Coverage Wells Fargo Outperform
2016-03-22 Initiated Coverage Wells Fargo & Co. Outperform
2016-01-07 Initiated Coverage Janney Montgomery Scott Buy $69.00
2015-02-20 Reiterated Rating Jefferies Group Hold $48.00 to $55.00
2014-11-03 Reiterated Rating Jefferies Group Hold $45.00 to $48.00
2014-08-05 Reiterated Rating Jefferies Group Hold $47.00 to $45.00
2014-02-10 Downgrade Ned Davis Research Buy to Neutral
2014-01-13 Upgrade Ned Davis Research Neutral to Buy
2013-11-04 Boost Price Target Jefferies Group Hold $36.50 to $45.00
2013-10-08 Initiated Coverage Bank of America Buy $50.00 to $39.88
2010-05-14 Reiterated UBS Neutral $41 to $44
2010-02-23 Initiated Jefferies & Co Buy $45
2008-12-19 Initiated
2008-02-29 Downgrade UBS Buy to Neutral
2007-11-05 Upgrade UBS Neutral to Buy
2007-10-08 Reiterated UBS Neutral $47 to $45
2007-08-20 Initiated UBS Neutral
2007-07-06 Initiated CL King Strong Buy $58
2007-02-21 Reiterated Lehman Brothers Underweight $43 to $45
2007-01-09 Downgrade Lehman Brothers Equal-weight to Underweight
2016-06-09 Reiterated Rating Jefferies Group Hold $67.00
2016-05-13 Reiterated Rating Janney Montgomery Scott Buy $69.00 to $90.00
2016-03-22 Initiated Coverage Wells Fargo Outperform
2016-03-22 Initiated Coverage Wells Fargo & Co. Outperform
2016-01-07 Initiated Coverage Janney Montgomery Scott Buy $69.00

There is presents forecasts of rating agencies and recommendations for investors about this ticker

Major Shareholders

Name Relationship Total Shares Holding stocks
MOREL DONALD E JR Chair of the Board & CEO 1.09%  (774186) CTLT / IART / WST /
FEDERICI WILLIAM J Sr. VP & CFO 0.28%  (195019) PATH / WST /
LUZZI RICHARD D Sr. VP, Human Resources 0.13%  (90723) WST /
Paproski John E President-Delivery Systems 0.11%  (78222) WST /
Green Eric Mark Chief Executive Officer 0.09%  (62997) SIAL / WST /
GAILEY JOHN R Sr. VP, Gen. Counsel & Sec. 0.09%  (62881) WST /
ZENNER PATRICK J 0.08%  (55680) ARQL / EXAS / WST /
ANDERSON MICHAEL A Vice President & Treasurer 0.08%  (55506) WST /
WEILAND JOHN H 0.06%  (45358) BCR / WST /
WELTERS ANTHONY 0.06%  (43535) BCR / CG / L / WST /
Bedwell Warwick President, Pharma Pkgs Systems 0.05%  (38778) WST /
Hofmann Thomas W 0.05%  (38250) NTI / PVR / WST /
Johnson Paula A 0.05%  (37402) WST /
Lennartz Heino President Europe 0.04%  (30707) WST /
Hunt Jeffrey C VP Pharma Pckg Systems 0.04%  (25953) WST /
Michels Douglas A 0.04%  (25607) OSUR / WST /
BUTHMAN MARK A 0.04%  (25607) IEX / KMB / WST /
Flynn Karen President, America\'s Region 0.03%  (21593) REPH / WST /
Feehery William F 0.03%  (20671) WST /
LAI GOLDMAN MYLA 0.02%  (11378) SQNM / WST /
Favorite Annette F Sr. VP Human Resources Officer 0.01%  (7404) WST /
MILLER GEORGE LLOYD Sr. VP, GC & Corp. Sec. 0.01%  (7403) SIAL / WST /
Malone Daniel Vice President & Controller 0.01%  (5454) WST /
Pucci Paolo 0.01%  (4802) ARQL / DYAX / NLNK / WST /
Abraham Silji Chief Digital & Trans Officer 0.01%  (4638) WST /